Quarterly report pursuant to Section 13 or 15(d)

Note 23 - Segment Information

Note 23 - Segment Information

3 Months Ended

Mar. 31, 2018

Note 23 - Segment Information

The Company is operating an acquisition and investment business. Majority owned subsidiaries of 51% or more are consolidated. The Company has determined that there are two reportable segments; 1) the cannabis and medical marijuana segment which includes the receivable from Bhang of $1,500,000, the fair value of securities investment in GW Pharmaceuticals plc (GWPH) stock, the equity investment in Electrum, convertible notes receivables and accrued interest from Electrum and NeuCourt, the notes receivable from G Farma, the contractual interest in the G Farma legal recovery, finance leases to G Farma and Pueblo West, and the operation of subsidiaries in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility related operating costs. The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below.

		Cannabis and Medical Marijuana Segment		Trash Management		Corporate and Eliminations		Consolidated
Three months ended March 31, 2018
Net sales	$	160,528	$	855,671	$	-	$	1,016,199
Operating income (loss)		76,765		26,487		(323,323)		(220,071)
Interest income		23,421		-		15,646		39,067
Interest expense		-		5,262		(1,134)		4,128
Property additions		-		-		2,399		2,399
Total assets		3,314,484		1,186,791		3,414,710		7,915,985
Depreciation and amortization		-		2,592		1,708		4,300

Three months ended March 31, 2017
Net sales	$	-	$	738,144	$	-	$	738,144
Operating income (loss)		(299)		36,275		(420,370)		(384,394)
Interest income		4,629		1		23,664		28,294
Interest expense		-		5,184		(1,134)		4,050
Property additions		-		-		-		-
Total assets		2,633,992		1,116,210		3,913,732		7,663,934
Depreciation and amortization		-		3,323		625		3,948

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

		Three Months Ended March 31,
		2018		2017
Operating loss	$	(220,071)	$	(384,394)
Interest income		39,067		28,294
Interest expense		(4,128)		(4,050)
Gain (loss) on investments		51,591		(81,566)
Other income (expense)		-		500

Income before income taxes	$	(133,541)	$	(441,216)